TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter earnings of $917.7 million. On a per-share basis, the Tarrytown, New York-based ...
Hosted on MSN16d
Regeneron beats quarterly estimates on eczema drug demand; launches dividend program(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales ... by lower inventory levels and a lower net selling price ...
Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter earnings of $917.7 million. On a per-share basis, the Tarrytown, New York-based company said it had profit of $8.06.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback